These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30550488)

  • 1. Effect of Macrolide Prophylactic Therapy on AIDS-Defining Conditions and HIV-Associated Mortality.
    Pasayan MKU; S Mationg ML; Boettiger D; Lam W; Zhang F; Ku SW; Merati TP; Chaiwarith R; Cuong DD; Yunihastuti E; Kiertiburanakul S; Van Kinh N; Avihingsanon A; Sun LP; Kamarulzaman A; Kantipong P; Kumarasamy N; Pujari S; Heng Sim BL; Ng OT; Choi JY; Tanuma J; Ross J; A Ditangco R
    J Acquir Immune Defic Syndr; 2019 Apr; 80(4):436-443. PubMed ID: 30550488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of disseminated Mycobacterium avium-complex infection in HIV patients receiving antiretroviral therapy with use of Mycobacterium avium-complex prophylaxis.
    Jung Y; Song KH; Choe PG; Park WB; Bang JH; Kim ES; Kim HB; Park SW; Kim NJ; Oh MD
    Int J STD AIDS; 2017 Dec; 28(14):1426-1432. PubMed ID: 28592210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team.
    Currier JS; Williams PL; Koletar SL; Cohn SE; Murphy RL; Heald AE; Hafner R; Bassily EL; Lederman HM; Knirsch C; Benson CA; Valdez H; Aberg JA; McCutchan JA
    Ann Intern Med; 2000 Oct; 133(7):493-503. PubMed ID: 11015162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome.
    Pierce M; Crampton S; Henry D; Heifets L; LaMarca A; Montecalvo M; Wormser GP; Jablonowski H; Jemsek J; Cynamon M; Yangco BG; Notario G; Craft JC
    N Engl J Med; 1996 Aug; 335(6):384-91. PubMed ID: 8663871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discontinuation of prophylaxis against Mycobacterium avium complex disease in HIV-infected patients who have a response to antiretroviral therapy. Terry Beirn Community Programs for Clinical Research on AIDS.
    El-Sadr WM; Burman WJ; Grant LB; Matts JP; Hafner R; Crane L; Zeh D; Gallagher B; Mannheimer SB; Martinez A; Gordin F
    N Engl J Med; 2000 Apr; 342(15):1085-92. PubMed ID: 10766581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opportunistic infections in HIV-AIdS.
    Paul SM
    N J Med; 2004 Nov; 101(11):25-31; quiz 32-4. PubMed ID: 15605797
    [No Abstract]   [Full Text] [Related]  

  • 7. Presence of macrolide resistance in respiratory flora of HIV-Infected patients receiving either clarithromycin or azithromycin for Mycobacterium avium complex prophylaxis.
    Aberg JA; Wong MK; Flamm R; Notario GF; Jacobson MA
    HIV Clin Trials; 2001; 2(6):453-9. PubMed ID: 11742432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disseminated mycobacterium avium-intracellulare complex (MAC) infection in the era of effective antiretroviral therapy: is prophylaxis still indicated?
    Lange CG; Woolley IJ; Brodt RH
    Drugs; 2004; 64(7):679-92. PubMed ID: 15025543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment and prophylaxis of disseminated Mycobacterium avium complex in HIV-infected individuals.
    Faris MA; Raasch RH; Hopfer RL; Butts JD
    Ann Pharmacother; 1998 May; 32(5):564-73. PubMed ID: 9606478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disseminated M. avium complex infection in the Swiss HIV Cohort Study: declining incidence, improved prognosis and discontinuation of maintenance therapy.
    Rossi M; Flepp M; Telenti A; Schiffer V; Egloff N; Bucher H; Vernazza P; Bernasconi E; Weber R; Rickenbach M; Furrer H;
    Swiss Med Wkly; 2001 Aug; 131(31-32):471-7. PubMed ID: 11641970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current strategies for the prevention and treatment of disseminated Mycobacterium avium complex infection in patients with AIDS.
    Wright J
    Pharmacotherapy; 1998; 18(4):738-47. PubMed ID: 9692648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance for AIDS-defining opportunistic illnesses, 1992-1997.
    Jones JL; Hanson DL; Dworkin MS; Alderton DL; Fleming PL; Kaplan JE; Ward J
    MMWR CDC Surveill Summ; 1999 Apr; 48(2):1-22. PubMed ID: 12412613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy.
    Karakousis PC; Moore RD; Chaisson RE
    Lancet Infect Dis; 2004 Sep; 4(9):557-65. PubMed ID: 15336223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is primary mycobacterium avium complex prophylaxis necessary in patients with CD4 <50 cells/μL who are virologically suppressed on cART?
    Yangco BG; Buchacz K; Baker R; Palella FJ; Armon C; Brooks JT;
    AIDS Patient Care STDS; 2014 Jun; 28(6):280-3. PubMed ID: 24833016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group.
    Havlir DV; Dubé MP; Sattler FR; Forthal DN; Kemper CA; Dunne MW; Parenti DM; Lavelle JP; White AC; Witt MD; Bozzette SA; McCutchan JA
    N Engl J Med; 1996 Aug; 335(6):392-8. PubMed ID: 8676932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discontinuation of Mycobacterium avium complex prophylaxis in patients with a rise in CD4 cell count following highly active antiretroviral therapy.
    Gill J; Moyle G; Nelson M
    AIDS; 1998 Apr; 12(6):680. PubMed ID: 9583614
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of disseminated Mycobacterium avium complex infection with reduced dose clarithromycin in patients with advanced HIV disease.
    Hewitt RG; Papandonatos GD; Shelton MJ; Hsiao CB; Harmon BJ; Kaczmarek SR; Amsterdam D
    AIDS; 1999 Jul; 13(11):1367-72. PubMed ID: 10449290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylaxis of Mycobacterium avium complex bacteremia in patients with AIDS.
    Gordin F; Masur H
    Clin Infect Dis; 1994 Apr; 18 Suppl 3():S223-6. PubMed ID: 8204774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention and treatment of disseminated Mycobacterium avium complex infection in human immunodeficiency virus-infected individuals.
    Shafran SD
    Int J Infect Dis; 1998; 3(1):39-47. PubMed ID: 9831675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of an AIDS patient with prolonged Mycobacterium avium bacteremia, high HIV RNA, HBV infection, Kaposi's sarcoma and cytomegalovirus retinitis.
    Furukawa Y; Hamada H; Kamikawaji K; Unoki T; Inoue H; Tashiro Y; Okamoto M; Baba M; Hashiguchi T
    J Infect Chemother; 2020 Feb; 26(2):279-281. PubMed ID: 31543435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.